The crosstalk between ferroptosis and cellular senescence in gestational diabetes mellitus: from iron dyshomeostasis to trophoblast dysfunction
- 1Department of Obstetrics, Qingdao University Affiliated Hospital
- 2Department of Gynecology, Qingdao University Affiliated Hospital
Abstract
Gestational diabetes mellitus (GDM) comprises heterogeneous placental phenotypes that include fetal overgrowth, large-for-gestational-age birth, and fetal growth restriction (FGR). We propose a testable endotype model in which maternal hyperglycemia, advanced glycation end products, diabetic dyslipidemia, altered polyunsaturated fatty-acid delivery, gestational iron exposure, and the physiologic fall in hepcidin converge on a redox-stressed trophoblast microenvironment. In proliferative cytotrophoblasts and extravillous trophoblasts, the relative reserve of GPX4 and FSP1/CoQ10, ACSL4-dependent PUFA-phospholipid loading, proliferative status, and insult intensity and duration are predicted to determine whether cells undergo ferroptosis, enter senescence, or occupy an intermediate state. We further propose an asymmetric crosstalk model: senescent trophoblasts are relatively ferroptosis-resistant, retain iron, and act in trans through SASP factors, reactive oxygen species, and oxidized lipids on ferroptosis-susceptible neighboring cells. The model predicts a gestational-age-dependent window in which physiologic senescence accumulates and its paracrine effects become injurious. Ferrostatin-1 or liproxstatin-1 should rescue lipid-peroxidation-driven death in susceptible cells without reversing senescence in iron-retaining cells. The model is GDM-specific in its initiating inputs and gestational context, but the reciprocal links remain hypotheses rather than established facts. It predicts that an injury-dominant placental endotype will show spatially adjacent iron-retaining senescence-like cells and lipid-peroxidation-driven cell death, impaired nutrient transport, and FGR, whereas compensatory transport and villous expansion may produce large-for-gestational-age phenotypes in other GDM placentas. We outline experiments that could support or falsify this model and define pregnancy-specific safety constraints for therapeutic testing.
Related
- Transition metal dyshomeostasis-associated macrophage dysfunction: potential roles in chronic metabolic diseases
- Hypoxia-Driven CA2 Promotes Trophoblast Dysfunction in Preeclampsia.
- Hepatocyte senescence in metabolic dysfunction–associated steatotic liver disease (MASLD)
- Commentary: Wogonoside alleviates metabolic dysfunction-associated steatohepatitis by modulating AMPK and xCT/GPX4 pathways to restrain lipid dysregulation and ferroptosis
- A Bi-Adjuvant Senolytic Nanovaccine Modulating Dendritic Cell Senescence Ameliorates Aging-Related Metabolic Dysfunction.
BibTeX
@article{li2026crosstalk,
title = {{The crosstalk between ferroptosis and cellular senescence in gestational diabetes mellitus: from iron dyshomeostasis to trophoblast dysfunction}},
author = {Min Li and Wendi Zhao and Lei Jiang and Yijing Chu},
journal = {Frontiers in Endocrinology},
year = {2026},
month = oct,
doi = {10.3389/fendo.2026.1975811},
url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1975811/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The crosstalk between ferroptosis and cellular senescence in gestational diabetes mellitus: from iron dyshomeostasis to trophoblast dysfunction
AU - Min Li
AU - Wendi Zhao
AU - Lei Jiang
AU - Yijing Chu
PY - 2026
DA - 2026/10/30
JO - Frontiers in Endocrinology
DO - 10.3389/fendo.2026.1975811
UR - https://www.frontiersin.org/articles/10.3389/fendo.2026.1975811/full
AB - Gestational diabetes mellitus (GDM) comprises heterogeneous placental phenotypes that include fetal overgrowth, large-for-gestational-age birth, and fetal growth restriction (FGR). We propose a testable endotype model in which maternal hyperglycemia, advanced glycation end products, diabetic dyslipidemia, altered polyunsaturated fatty-acid delivery, gestational iron exposure, and the physiologic fall in hepcidin converge on a redox-stressed trophoblast microenvironment. In proliferative cytotrophoblasts and extravillous trophoblasts, the relative reserve of GPX4 and FSP1/CoQ10, ACSL4-dependent PUFA-phospholipid loading, proliferative status, and insult intensity and duration are predicted to determine whether cells undergo ferroptosis, enter senescence, or occupy an intermediate state. We further propose an asymmetric crosstalk model: senescent trophoblasts are relatively ferroptosis-resistant, retain iron, and act in trans through SASP factors, reactive oxygen species, and oxidized lipids on ferroptosis-susceptible neighboring cells. The model predicts a gestational-age-dependent window in which physiologic senescence accumulates and its paracrine effects become injurious. Ferrostatin-1 or liproxstatin-1 should rescue lipid-peroxidation-driven death in susceptible cells without reversing senescence in iron-retaining cells. The model is GDM-specific in its initiating inputs and gestational context, but the reciprocal links remain hypotheses rather than established facts. It predicts that an injury-dominant placental endotype will show spatially adjacent iron-retaining senescence-like cells and lipid-peroxidation-driven cell death, impaired nutrient transport, and FGR, whereas compensatory transport and villous expansion may produce large-for-gestational-age phenotypes in other GDM placentas. We outline experiments that could support or falsify this model and define pregnancy-specific safety constraints for therapeutic testing.
SN - 1664-2392
ER -